Analytical characterization and comparison of the blood–brain barrier permeability of eight opioid peptides-Reference-Cited by-同舟云学术

Analytical characterization and comparison of the blood–brain barrier permeability of eight opioid peptides

Published:2010-07 Issue:7 Volume:31 Page:1390-1399
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Van Dorpe Sylvia,Adriaens Antita,Polis Ingeborgh,Peremans Kathelijne,Van Bocxlaer Jan,De Spiegeleer Bart

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference103 articles.

1. Structure and function of the blood–brain barrier;Abbott;Neurobiology of Disease,2010

2. Blood–brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine;Abbruscato;Journal of Pharmacology and Experimental Therapeutics,1997

3. Converting a peptide into a drug: strategies to improve stability and bioavailability;Adessi;Current Medicinal Chemistry,2002

4. Peripheral mechanisms of intestinal dysmotility in the morphine tolerant and dependent rats;Banach;Journal of Physiology and Pharmacology,2006

5. Delivery of peptides to the brain: emphasis on therapeutic development;Banks;Biopolymers,2008

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomimetic Dual-Target Theranostic Nanovaccine Enables Magnetic Resonance Imaging and Chemo/Chemodynamic/Immune Therapy of Glioma;ACS Applied Materials & Interfaces;2024-05-15

2. Analgesic tolerance and cross-tolerance to the bifunctional opioid/neuropeptide FF receptors agonist EN-9 and μ-opioid receptor ligands at the supraspinal level in mice;Neuropeptides;2023-02

3. Mu-opioid receptor-dependent transformation of respiratory motor pattern in neonates in vitro;Frontiers in Physiology;2022-07-22

4. Effects of backbone cyclization on the pharmacokinetics and drug efficiency of the orally active analgesic conotoxin cVc1.1;Medicine in Drug Discovery;2021-06

5. Topical treatment with a mu opioid receptor agonist alleviates corneal allodynia and corneal nerve sensitization in mice;Biomedicine & Pharmacotherapy;2020-12